"Omics" prescriptions for international medical community recognition

Time: 2015-09-14

Source: China's traditional Chinese medicine

The author: the fall of the qin dynasty

Report from our correspondent (reporter in the fall of qin) in August 2015, the famous international journal of Pharmacology "modern Vascular Pharmacology" (the Current Vascular Pharmacology) published the "omics" prescriptions (Fangjiomics), marked the emerging discipline of TCM original thinking in the international medical academic breakthrough, inheritance and innovation of TCM achievements toward internationalization.

Honorary President of the China academy of traditional Chinese medicine wang yongyan academicians and researchers worsley with the university of Nevada, a professor at the period of great leap of international research team, in the overall view and under the guidance of theory of syndrome differentiation of TCM, innovation in introducing modern omics, systems biology, bioinformatics, chemical biology, Pharmacology and multidisciplinary technology such as network Pharmacology, and through "disease - syndrome - targets - (traditional Chinese medicine compound prescriptions" multiple links, across the single target research model, from the viewpoint of hierarchy, holistic, systematic explore network of commonly used Clinical pharmacological mechanism, from the ion channels, particles, signaling pathways reveals the joint treatment of complex diseases, and explore the development based on the advantages of syndrome differentiation and treatment of the Clinical syndrome of Pharmacology, for the first time in 2011 in the international Journal of Clinical Pharmacology (Journal of Clinical Pharmacology) put forward "omics" prescriptions, has drawn great attention of the international medical profession.

In recent years, in the ancient traditional medicine prescriptions combined with modern technology has made great progress, the existing research results show that the prescription group learning can provide quality controllable, mechanisms, clear the queue design treatment strategy, thus less through the use of drug combinations, targeting the function of reasonable and less off-target effects, which is expected to conquer the joint treatment of complex diseases many key problems faced by, represents a complex disease individualized treatment in the future the development direction of clinical pharmacology and treatment strategies.

Omics prescriptions edition in east of western medicine in the era of phenotypic omics collision as the theme, collected from China, Hong Kong, China and the United States on vascular disease combined treatment of omics in prescriptions and article 13. Special issue published will further promote international academic significance of combined treatment prescriptions complexity disease and the understanding of the mechanism of action, effectively promote the individual joint strategy and the development of precision medical treatment.